Atomos Limited (ASX:AMS) Enters $13.7m Debt Facility
Atomos Limited (ASX:AMS) secures a $13.7m debt facility to achieve cashflow positivity by FY26, avoiding equity dilution.
Atomos Limited (ASX:AMS) secures a $13.7m debt facility to achieve cashflow positivity by FY26, avoiding equity dilution.
PlaySide Studios (ASX:PLY) restructures operations to optimize costs while maintaining focus on major IP projects and future growth.
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
xReality Group Limited (ASX:XRG) enters into a debt refinancing agreement with Causeway Asset Management to strengthen its financial position and support growth.
Archer Materials (ASX:AXE) appoints Dr Simon Ruffell as CEO, enhancing leadership with his extensive experience in semiconductor and quantum technologies.
Healius (ASX:HLS) reveals a new pathology strategy and a $300 million special dividend during Investor Day 2025.
Tuas Limited (ASX:TUA) reports a 34% revenue increase and returns to profitability in its latest interim financial report.
I Synergy Group Limited (ASX:IS3) requests a trading halt to complete a proposed capital raising, expected to resume by 27 March 2025.
Helia Group Limited (ASX:HLI) announces its 2025 Annual General Meeting, featuring key resolutions on share buy-backs and director elections.
Adveritas Limited (ASX:AV1) achieves a $1 million record annual contract value and anticipates over $5 million from multi-year renewals, advancing its market position.